Cancer and ageing in mice and men. by Peto, R. et al.
Br. J. Cancer (1975) 32, 411
CANCER AND AGEING IN MICE AND MEN
H. PETO,1 F. J. C. ROE,2 P. N. LEE,3 L. LEVY2 AND J. CLACK2
Fronm the 'Radcliffe Infirmiary, I niversity of Oxford, 'Chester Beatty Research Institute (Pollard's
110oo( Research Station), Institute of Cancer Research, London, and the 3Tobacco Research
Council, Glen House, Stag Place, London SWX'IE 5AG
Receivedl 2 June 1975. Accepte(t 10 July 1975
Summary.-In an experiment involving 950 mice with a normal lifespan of 2-3
years, in laboratory conditions, regular benzpyrene application to the skin was
started at 10, 25, 40 or 55 weeks of age. The incidence rate of malignant epithelial
tumours among the survivors in each group increased steeply with time. This
increase was associated directly with duration of exposure but, given duration,
was independent of age at the start of exposure, as were the growth rates of already
established tumours.
In our experiment, although age per se was irrelevant, the cancer incidence rate
increased approximately as a power of the duration of exposure to benzpyrene.
This shows that the observed approximate power-law increase of most human
adult cancer incidence rates with age could exist merely because age equals duration
of exposure to background and spontaneous carcinogenic stimuli. Thus, no in-
trinsic effects of ageing (such as failing immunological surveillance or age related
hormonal changes) whatever need be postulated to explain the vast increases in
old age of the incidence rates of such human cancers. This result can greatly
simplify speculation about mechanisms of carcinogenesis.
THE STRONGEST determinant of cancer
incidence rates* in man appears to be
age. The probability that a man will
develop cancer in the next 5 years is
one in 14 if he is 65, but only one in
700 if he is 25 (figures for Birmingham,
U.K., from Doll, Muir and Waterhouse,
1970). This relative risk is 50 to one,
and differences in cancer incidence rates
between young adults and old adults
of this order of magnitude are found
in many species other than man. In
countries with adequate cancer registries,
total cancer incidence can be separated
into age-specific incidence rates for each
site, and between the ages of 25 and 64
many of these separate rates increase
approximately as the fourth, fifth or sixth
power of age.
In this paper, we describe an attempt
to determine experimentally whether these
marked increases with age arise because
unreversed effects of continued exposure
to carcinogens accumulate with time or
whether they arise because ageing affects
the carcinogenic process in other ways.
Local multistage model
There is evidence that the change
from the normal to the cancerous state
can take place in distinct " stages ",
each with its own causes. It has been
shown in the case of mouse skin, for
example, that exposure to a tumour
initiating stimulus (which may be a sub-
carcinogenic dose of a skin carcinogen
or one or more doses of an incomplete
carcinogen, i.e. an agent which by itself
is incapable of giving rise to skin cancers)
may result in skin cancer formation if
these is subsequent exposure to a tumour
promoting agent, whereas exposure to
* The incidence rate of a cancer at a partictular age is the proportion per unit time of people of that
age who develop the cancer of interest.R. PETO, F. J. C. ROE, P. N. LEE, L. LEVY AND J. CLACK
the same 2 agents in the reverse order
does not result in skin cancer (Berenblum
and Shubik, 1947; Roe, 1959). Although
there may be some loss of effect of expo-
sure to a tumour initiating agent if the
promotor is given a long time after the
initiator (either because of repair or
because of selective destruction or shed-
ding of altered cells, Roe et al., 1970),
there is abundant evidence from studies
of experimental animals or of humans
exposed to occupational or other carcino-
gens that some increased risk of cancer
development among exposed groups may
persist for long periods after exposure
ceases.
In this paper, we frequently consider
multistage models in which each stage
is an irreversible, heritable, mutation-like
event suffered by particular cells, and
if one cell happens to suffer a certain
set of " stages " it is then able to pro-
liferate into a recognizable cancer. Such
" local multistage models " do not require
systemic stages (e.g. mutations in the
immune system) which affect the whole
organism. Although the experiments of
Berenblum and Shubik (1947) demonstrate
that some ordering of these cellular
stages is probable, it does not follow that
all the stages have to occur in a fixed
order. Ifthe " stages " are just particular
changes in single stem cells, then their
rates of occurrence can be described by
rate-constants* (just as the rates ofsimple
chemical reactions can), and the rate-
constant of each stage may depend on
which other stages have preceded that
stage. This might, for example, occur
if an early stage impairs the DNA repair
enzymes or the enzymes involved in the
mitotic process, thus predisposing to
subsequent mutations. If the rate-con-
stant for a stage is zero until certain
other specific stages have occurred, then
some ordering of the stages is essential.
In a local " multistage " model such
as this, the changes (i.e. stages), once
they have occurred in a particular cell,
are not repaired but remain forever
present in that cell and in all its descen-
dants, so the proportion of the cells in
the tissue with one particular change
will increase with the passage of time
as further exposure to carcinogens (and,
perhaps, to mistakes in gene replication
during routine mitosis) continues. If a
number of specific changes are necessary
before a cell can proliferate into a recog-
nizable cancer, then the proportion of
cells which have suffered all those changes
will, even if the changes are not entirely
independent of each other, increase as
time passes rather like the product of
several things that themselves increase
with age, and will therefore increase very
sharply with age. The simplest assump-
tion is that the rate-constant for each
stage is either constant or, alternatively,
negligible until certain other stages have
occurred and constant thereafter. This
yields the model of Armitage and Doll
(1961), in which cancer incidence increases
as a simple power of age. This " power
law relationship " is, in fact, how several
cancers do depend on age during adult
life. (A power law relationship is still
obtained if it is assumed that a cell
which has undergone certain stages then
undergoes a limited proliferation into
a monoclonal carcinoma in situ or papil-
loma, and we intend our multistage model
to embrace such possibilities.)
Alternatives to the local multistage model
The " local multistage model " is
capable, therefore, ofexplaining the strong
dependence of cancer incidence rates on
age merely by postulating that several
heritable cellular alterations are necessary
to produce a cell which can proliferate
into a cancer. However, it may be that
there are additional reasons why cancer
rates increase sharply in old age. For
* The kinetic rate-constant for the occurrence of a stage among cells of a certain type is the expected
proportion per unit time of such cells which suffer this stage. For a consideration of some factors which
might govern mutation rates in stem cells see Cairns (1975). For evidence that most malignant tumours do
arise from the uncontrolled proliferation of a single stem cell see Fialkow (1974).
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example, Burnet (1970) has suggested
that in young people immunological sur-
veillance mechanisms might be much
more efficient at eliminating changed cells
before they manage the final stage, which
is proliferation to form cancer, and
Dilman (1971) has suggested that tumori-
genesis might be promoted by hormonal
changes due to age related changes in
the hypothalamus. Alternatively, it may
be that the kinetic rate-constants for
one or more of the changes involved in
carcinogenesis (some of which are pre-
sumably mutation-like events) increase
with age, perhaps because stem cells
have to divide increasingly frequently
to maintain ageing tissues in an intact
state.
Two hypotheses are therefore possible:
either (Hypothesis 1), ageing (by some
intrinsic mechanism) might generally have
some substantially greater relevance than
that suggested by the mere postulate
of a local multistage model, or, secondly
(Hypothesis 2), the increase in the in-
cidence rates of many cancers with age
is generally due not to any substantial
intrinsic effect of ageing but rather to a
steady accumulation with time (and
therefore unavoidably with age) of each
of several kinds of specific change in the
cells of the target tissue, the kinetic
rate-constants of these changes being
perhaps dependent on which stages that
cell has already passed through, but
being otherwise approximately indepen-
dent of age.
The simple local multistage model
with no intrinsic effects of age predicts
that an approximate power law relation-
ship between cancer incidence and age
will exist: for the childhood cancers and
for certain cancers of adult life (e.g.
breast cancer, testicular cancer and pro-
static cancer) this relationship is not
observed and so the simple local multi-
stage model is not plausible. However,
for most cancers of adult life an approxi-
mate power law relationship between
incidence rate and age does exist and it
is only with such cancers that we wish
to be concerned. A simple local multi-
stage model will lead to a power law
relationship, and Hypothesis 2 is the
" null hypothesis " which says that in
general no substantial intrinsic effect
of ageing exists on the induction of those
cancers of adult life whose incidence
rates exhibit an approximate power law
increase with age. However, even a
fourth-power relationship between inci-
dence and age implies a very sharp
increase indeed in old age, and this has
led many authors to posit Hypothesis 1,
which says that part at least of this sharp
increase is due not merely to the " local
multistage " accumulation of altered cells
with time but to some other intrinsic
effect of old age.
To distinguish between Hypotheses 1
(some intrinsic effect of ageing) and 2
(no such effect) experimentally, various
approaches are possible.. Clear proof of
Hypothesis 1 would be provided if an
age related process which did substantially
affect the incidence of many " power
law " cancers could be discovered, but
none ever has been. Hypothesis 1 would
also be demonstrated if transplanted
tissue of a particular age in syngeneic
hosts of different ages showed a suscepti-
bility to cancer induction which depended
strongly on the age of the host, but this
experiment has never been performed.
Much of this present paper is concerned
with the experimental system in which
continuous exposure to a carcinogen
starting in youth is compared with the
same continuous exposure starting later
in life. If, by the time the later exposure
starts, sufficient changed cells have al-
ready accumulated by spontaneous or
background processes to appreciably in-
crease the cancer crop in the older
organisms, then both Hypothesis 1 and
Hypothesis 2 agree that the carcinogenic
treatment which starts later will produce
cancers more rapidly and so such a result
would not discriminate between the 2
hypotheses. However, if no such accu-
mulation has occurred, Hypothesis 2
would predict equal responses at both
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ages whereas most versions of Hypothesis
1 would not. (The sole exception is if
the spontaneous rate-constant for a parti-
cular stage increases from slight to
moderate with advancing age, and in the
presence of the carcinogen that rate-
constant is massively increased by an
amount independent of age.) Because
we find Hypothesis 2 intrinsically plaus-
ible, we have performed an experiment
of the kind that is capable of disproving
most versions ofHypothesis 1, rather than
an experiment which could have dis-
proved Hypothesis 2 but could not dis-
prove Hypothesis 1.
Previous epidemiological and experimental
evidence
On the assumption that cigarette
smoking is the major determinant of
lung cancer, we can attempt to dis-
criminate between these hypotheses from
available human data. According to
Kahn (1966), the annual lung cancer
death rate per 100,000 for currently
smoking males aged 55-64 is 251 for
those who began to smoke before they
were aged 15 and 53 for smokers who
started after age 25. For currently smok-
ing 65-75 year old males, the rates were
478 and 162 respectively. As can be
seen from Table I, these 4 death rates
can all be taken as proportional to dura-
tion of smoking to the fourth power.
Kahn's findings can therefore be explained
satisfactorily by Hypothesis 2 (i.e. the
local multistage model with no intrinsic
effect of age).
Doll (1971a), in a recent review article,
also concluded that data for human
cancer in general support Hypothesis 2.
He said " it seems unlikely that age per
se is a principal factor in determining the
frequency ... and there is no consistent
difference in the susceptibility to cancer
induction when individuals are exposed
to the same agent at different ages ".
Nevertheless, the human data are not
well controlled, the only animal experi-
ment previously reported was small (Lee
and Peto, 1970), and it seemed worth
TABLE I. Relationship between Latng Can-
cer Incidence Rate, Age and Age at
Starting to Smoke for Lifelong Smokers
of Cigarettes. (Data from Kahn, 1966)
Age (years) ofpopula-
tion at risk
Approximate mean
age at risk
Age at starting to
smoke
Approximate mean
age at starting to
smoke
Approximate dura-
tion of smoking
(years)
Observed lung can-
cer death rate per
100,000 p.a.
Number of deaths
from lung cancer
(a) Observed
(b) Expected*
55-64
60
65-74
68
Under Over Under Over
15 25 15 25
13 28 13 28
47 32
251
55 40
53 478 162
70 30 65 70
74-3 32-4 67-9 60-4
* Using the above approximate durations and
assuming that lung cancer incidence rates are
proportional to the fourth power of duration of
smoking, and making the total expected numbers
equal the total observed.
while to undertake a large and well
controlled animal experiment to answer
the question. Doll (1971b) predicted that
it should be possible to decide this issue
definitively. The e*periment described
in the present paper goes a long way
towards doing this.
MATERIALS AND METHODS
Mice and details of treatment.-The ex-
periment was carried out in a closed animal
unit under barrier conditions. Nine hundred
and fifty female mice of a random-bred
Swiss albino strain born in one part of the
unit were, at the age of 5 (+ 1) weeks,
transferred to a room in another part of the
unit set aside for the experiment. At this
time they were randomly allocated to groups
1, 2, 3 or 4, which consisted respectively of
140, 170, 220 and 420 mice. They were
housed in macralon boxes, 10 per box, given
autoclaved wood shavings as bedding, and
provided ad libitum with water and an
autoclaved vitamin fortified diet based on
the 41B formula (supplied by Spillers Ltd).
The normal lifespan of such mice in these
conditions is 2-3 years.
At the age of 10 weeks, and at weeklv
intervals thereafter, the backs of the 140
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mice of Group 1 were shaved from the
neck to the root of the tail, using clippers
lubricated with Liquid Paraffin, B.P.C.
(which does not cause skin tumours wxvhen
applied to the skin of mice). From the
same age, 20 Hg of benz(a)pyrene (BP) in
0-25 ml of acetone was applied twice each
week by pipette to the shaved back. Pre-
vious experience with this treatment sug-
gested that malignant skin tumours would
be produced after 1-2 years of regular
treatment. The BP w-as obtained from
L. Light & Company, and the acetone
(Analar grade) from Messrs Hopkins &
Williams. At fortnightly intervals after the
start of regular painting, ' charting " occur-
red: the backs of the animals wNere examined
and any visible and/or palpable lumps
apparently arising from the epithelium
were noted and measured. Three sets of
callipers w%ere available, set with gaps of
2 mm, 6 mm and 10 mm between blunted
points, and at each fortnightly charting it
was noted whether the diameters of lumps
exceeded these calliper settings. When a
lump which appeared to be arising from the
epithelium exceeded 10 mm, the mouse was
killed and sections 6 ,tm thick prepared
from the lump and stained wvith haematoxylin
and eosin for histological examination. The
same procedure as adopted for the mice
of Groups 2, 3 and 4, except that shaving
and regular BP administration were started
at 25 weeks of age in Group 2, at 40 weeks
of age in Group 3, and at 55 wveeks of age in
Group 4.
All mice Awere examined at least once
daily on 7 days per week for sickness or
death. Sick mice ere killed. No animal
with a 1l0 mm diameter lump wvas lost
because of cannibalism or advanced auto-
lysis.
When animals died or were killed, lumps
of any size in the subcutaneous tissues in
the shaved area were taken for histological
examination, in addition to 10 mm lumps
apparently arising from the skin surface.
Many of the subcutaneous lumps proved
to be sarcomata and none w%vere 10 mm
epithelial tumours. However, 9 out of the
total of 500 10 mm lumps wNhich appeared
to be arising from the epithelium were not,
in fact, epithelial tumours: 8 were sarcomata
and one was an ulcerating cyst associated
with a malignant lymphoma.
Statistical analysis. Because the observed
incidence of news tumours during a particular
fortnight may well be, for example, only
2/100, which is so small that it is unstable,
we need some stable way of displaying the
incidence rates in each of the 4 groups so
that the overall pattern is not lost in random
variation. The cumulative incidence"
(Peto, 1974) and the " life-table " (Pike
and Roe, 1963) are equally useful for this
purpose. Both use the fact that the sum
of many small, individually unstable in-
cidence rates is quite stable. The life-table
gives the percentage of animals which
wAould still be tumourless if the observed
incidence rates affected a population of
animals which did not die from other causes:
although this is somewhat hypothetical, it
does give us some feeling for what the
life-table means, and so we have displayed
our results by means of life-tables, calling
the vertical axis ' 00 mice without tumours ".
Although the main interest of the experi-
ment was in the qualitative dependence of
incidence on duration of treatment and on
age given duration of treatment, a quantita-
tive comparison between Group 1, which
started regular treatment at 10 wreeks of age,
and Group 4, which started regular treat-
ment at 55 weeks of age, was performed
using methods appropriate for ' non-inci-
dental " tumours (Peto, 1974).
It made no material difference to the
results of our analysis whether we compared
"time to first 2 mm epithelial tumour",
"time to first 6 mm epithelial tumour"
or "' time to first 10 mm epithelial tumour"
in the 4 groups. Of these analyses, " time
to first 10 mm epithelial tumour" seemed
the most biologically relevant, since a
greater proportion of the 2 mm and 6 mm
tumours were benign, and so this is the only
one reported in detail.
Since tumours were " charted " only
once every fortnight, if a tumour reached
10 mm between 2 chartings it would not be
recorded as having done so until the second
charting. Time is therefore divided into
fortnights and we only know that 10 mm
tumours detected at the end of a fortnight
reached 10 mm at some time during that
fortnight. The sizes of skin tumours in
mice which died or were killed between
chartings were measured and it was assumed
that mice which died in the first half of the
fortnight without 10 mm tumours had not
been
" at risk " for that fortnight while
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mice which died in the second half had
been. In a few mice more than one skin
tumour grew to a diameter of 10 mm or
more during one fortnight. In these cases
the animal was categorized using only the
most malignant of its 10 mm skin tumours.
Sections were obtained from all 10 mm
tumours without exception, but sections
from 10 of these tumours were lost. All
10 were, from the description of their ap-
pearance in vivo, epithelial tumours and
have been assumed to be such in the pre-
sentation and analysis of the results.
RESULTS
Histology of 10 mm epithelial tumours
Almost all of these epithelial tumours
were malignant: of the 481 from which
sections reached the histologist, 427 (89%)
showed infiltration of the panniculus
muscle and in the opinion of the patho-
logist (FJCR) a further 42 (9%) were
also malignant since they showed invasion
of the dermal tissues, although not of
the panniculus muscle. There would be
no disagreement among pathologists about
the malignant nature of the tumours
which showed invasion of the panniculus,
but the malignant status of some of the
other tumours might be disputed. We
therefore concluded only that over 90%
of the 10 mm epithelial tumours were
unequivocally malignant.
There was no difference between the
4 treatment groups in the proportions
of 10 mm tumours which showed in-
filtration of muscle (Table II) and so our
analysis would yield similar results even
if we had restricted our interest still
further to only those 10 mm epithelial
tumours which were infiltrating the pan-
niculus muscle.
Comparison of Hypotheses 1 and 2 for
incidence rates of 10 mm epithelial tumours
If benzpyrene acts on the first stage
of the progression of normal cells towards
malignancy, we would expect very dif-
ferent results under Hypotheses 1 and 2
if we plotted the life tables for the 4
treatment groups against age and then
against duration of exposure. Figure 1
displays the expected pattern of results
under Hypothesis 2 (in which incidence
rate depends wholly on treatment dura-
tion and, given this, not at all on age)
and under the most extreme version of
Hypothesis 1 (in which incidence rate
depends wholly on age and, given this,
not at all on treatment duration); the
actual results are set out in Fig. 2. The
complete data from which Fig. 2 was
derived are set out in the Appendix.
It is clear that the extreme version of
Hypothesis 1 is completely untenable:
the increased rate of production of
tumours after prolonged exposure to
benzpyrene cannot plausibly be attributed
to mice becoming more susceptible to
benzpyrene as they grow older. Hypo-
thesis 2 is extremely plausible, however:
the response of mouse skin to benzpyrene
can be explained very satisfactorily in
terms of duration of exposure. There is
in fact no indication at all of age having
any substantial effect after duration of
treatment is taken into account. The
actual numbers of 10 mm epithelial
tumours observed in the 4 groups are
TABLE I.-Numbers of 10 mm Epithelial Tumours which were Found to have (a) Infil-
trated the Panniculus Carnosus and (b) Not, by Treatment Group
Age (weeks) when
regular application
began
10
25
40
55
Treatment
group
1
2
3
4
No. of
mice
140
170
220
420
(a)
Infiltrated
93
115
99
120
(b)
Not
12
13
16
13
Percentage
found to have
infiltrated
89%
90%
86%
90%
Section
lost
5
0
4
1
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THE MOST EXTREME
HYPOTHESIS I PREDICTIONS
100
GROUPS
123ond4 50
80
AGE (weeks)
AGE (weeks)
42 1
25 40 55 70
EXPOSURE DURATION (weeks)
I'.t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~I
70
EXPOSURE DURATION (weeks)
FIG. 1. Life tables depictingpercentages oftumourless mice against (a) age, (b) duration ofexposure
to benzo(a)pyrene under Hypotheses 1 and 2.
displayed in Table III, together with
the duration of exposure at which the
life-table " per cent tumourless " reaches
various values.
It is noteworthy that the life-table
technique allows us to recognize that a
crop of 134/420 (32%) in Group 4 and
a crop of 110/140 (79%) in Group 1
actually represent very similar carcino-
genic responses: the main tumour crop
appeared after more than one year of
treatment and these different absolute
incidences arose merely because far more
of the 420 animals of Group 4 which
started exposure to BP at age 55 weeks
died before they had a chance to develop
a skin cancer. This similarity is emphas-
ized by the fact that, using a logrank
test (Peto and Pike, 1973), the difference
between Groups 1 and 4 in time from
starting BP to developing a tumour is
not statistically significant (P > 10%).
The incidence in the older mice was, in
fact, slightly but not significantly lower
than in the younger mice with a similar
duration of BP exposure.
Comparison of Hypotheses 1 and 2 for
tumour growth rates from 2 mm to 10 mm
Another way in which ageing tissue
might differ from younger tissue is in
the rate at which established tumours
grow. In laboratory animals exposed
to carcinogens, it is commonly true that
the tumours which arise early grow more
rapidly than those that arise later. A
possible explanation is that faster growth
seen after a tumour has reached a detect-
able size is matched by faster growth
from the time of induction to detectable
size, i.e. rapid growth caused early ap-
pearance. Alternatively, thegrowth rates
of tumours originating in ageing tissues
might be essentially slower. The present
experiment enables us to test these
possible explanations, since we are able
to compare the times taken to grow from
2 mm to 10 mm by tumours which reached
100
MICE
WITHOUT 50
TUMOURS
% 100
MICE
WITHOUT
TUMOURS 5
-
L
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w
E
100
U)
8 80"
Z 60-
| 40-
,, 20-
Ei
AGE (weeks)
(a)
KEY
L .. '.3-
20 40 60 f0 100 120
EXPOSRE DURATION (weeks)
(b)
FIG. 2.-Actual forms of the life tables depicting percentages of tumourless mice against (a) age,
(b) duration of exposure to benzo(a)pyrene in Groups 1-4.
TABLE III.-Relationship of Crop of 10 mm Epithelial Tumours toRepeatedApplications
ofBenzo(a)pyrene (BP) to the Skin
Age (weeks) at start of regular BP
No. ofanimals allocated randomly (at age 5 weeks)
to the four groups
No. which developed a 10 mm epithelial tumour
Life-table estimate of the duration (in weeks) of
BP treatment by which, in the absence of
other causes of death
(a) 1% of mice
(b) 33% of mice
(c) 67% of mice
would have got a 10 mm epithelial tumour.
(The mice were examined fortnightly.)
Group 1
10
140
Group 2
25
170
Group 3
40
220
Group 4
55
420
110 128 119 134
44
64
74
46
64
74
44
68
78
44
66
78
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10 mm after similar durations of exposure
to BP in mice whose ages differed by up
to a year.
We find, as expected, that the mean
time since a 10 mm epithelial tumour was
2 mm is shorter for the 10 mm tumours
which arose earliest after the start of
treatment; the regression of " time since
2 mm" on "treatment duration at
10 mm" in weeks is 10 + (duration -
70.4) x 0419, the standard error of the
regression coefficient 0419 being ±0-02
and the standard deviation of (actual-
predicted) growth times being ±55 weeks.
However, it is not true that tumours
which arise after similar durations of
painting grow faster in younger animals;
the simultaneous regression coefficients
of " time since 2 mm " on " treatment
duration at 10 mm " and " age at 10 mm "
are 04190 ± 0-022 and 0-006 ± 0-013.
In summary, growth rates, like in-
cidence rates, depend on duration of
exposure to benzpyrene (the most rapidly
growing tumours tending to be detected
sooner) but not at all on age given dura-
tion of exposure.
Test of the power-law increase of incidence
rates with duration of exposure
Since our aim in this experiment was
to compare various explanations for the
observed power-law increase with age
of many human adult cancer rates (in
which the incidence rate during adult
life is approximately a power of age),
we must check that our data exhibit,
at least approximately, a power-law
increase of cancer incidence rates with
duration of exposure.
In the human situation, where the
period of growth of a tumour may some-
times be onlv a small fraction of the
duration ofexposure, it may be reasonable
under the local multistage hypothesis to
expect a reasonably exact fit to this
relationship. However, the situation in
our experiment on mice is somewhat
different.
We know that the time taken for
tumours to grow from 2 mm diameter
(about 106 cells) to 10 mm diameter
(about 108 cells) is, on average, about
6 weeks for tumours arising after 50 weeks
of BP treatment, about 10 weeks for
tumours arising after 70 weeks of BP
treatment and about 14 weeks for tumours
arising after 90 weeks of treatment. In
other words, a 100-fold increase in the
numbers of cells is taking of order 2 or
3 months to complete. How long, on
average, has the growth from a single
malignant cell to a 10 mm tumour
taken? This question cannot be answered
directly but it seems unlikely to be less
than 6 months and may well be con-
siderably more, since the transition from
a single cell to a 2 mm tumour requires
three 100-fold increases and (since the
one observable 100-fold increase takes 2
or 3 months) these three 100-fold in
creases will presumably take at least
4 months to complete.
Because of this delay, we would not
expect the age-specific incidence rate of
the first tiny clones of malignant cells to
be exactly reflected in the age-specific
incidence rate of 10 mm epithelial tu-
mours. Moreover, random variation in
these delays will make the increase of
the incidence rate of 10 mm tumours
with exposure duration shallower than
the increase of the incidence rate of
first clones with exposure duration.
Despite these reservations, we have
plotted, for each fortnightly charting,
the percentage incidence of 10 mm
epithelial tumours observed at that chart-
ing on a logarithmic scale against duration
of BP exposure minus 61 months (the
value which generated the straightest
line), pooling all the data from Groups
1-4. The results of this are shown in
Fig. 3, and it is obvious that over the
100-fold range from 0 25% per fortnight
up to the massive incidence rate of 25%
per fortnight observed after 90 weeks of
regular BP administration, the points do
approximately fit a straight line. Meas-
urement ofthe slope of this line shows the
best-fitting whole number is three. This
means that the cancer incidence rates do
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a4512950OSERVED
j 25 29/ EXPECTED,-.
-J 10-
LLE 0 2.5-
> 05 _. 5 12 /703 EXPECTED
iI8 25 _ ! 5/703 OBSERVED ~~~~~~~~I II
- 50 60 70 80 90
EXPOSURE DURATION (weeks)
scale : 4xlog (duration-28)
Fic. 3. Incidence rates (as percentages) of 10 mm epithelial tumours at successive fortnightly
chartings against duration of BP application, on a log/iog scale from 28 weeks. These rates,
calculated from the poole(ldata of all 4 treatment gIroups, aIe statistically independlent of each
other and 90% confidence intervals are indicated.
increase approximately as the third power
of (duration 28 weeks). Our data may
therefore be relevant to the power-law
increase of human cancer incidence rates
with age. The only anomalies are at
weeks 50 and 70, and these are not serious
in view ofthe large number ofindependent
rates which are being examined. A single
mouse in Group 4 developed a 10 mm
infiltrating epithelial tumour at age 79
weeks in treatment week 24: this was
perhaps spontaneous, as such tumours
do arise in about 0.500 of untreated
control mice of this strain, but apart
from this no 10 mm epithelial tumours
arose before the 40th week of treatment.
After the 90th week of treatment, only
15 mice remained alive, 12 of which
already had epithelial tumours of less
than 10 mm diameter, and the calculation
of meaningful incidence rates became
impossible.
Body weight
Could differences in body weight and
growth rates between groups invalidate
the conclusions that we have so far
reached?
At the age of 10 weeks the mean
weight of the 950 mice in the experiment
was 28-8 g. Group 1, which received
BP from 10 weeks of age, grew more
slowly than the other groups. The re-
spective mean weights in grams of the
survivors in the four groups at 55 and
75 weeks of age were as follows:
Age
(weeks) 1
55 41-1
(125 mice)
75 42 8
(80 mice)
Group
2
42-5
(156 mice)
44 0
(141 mice)
3
43-2
(200 mice)
46-8
(194 mice)
4
45-3
(401 mice)
47 9
(377 mice)
The application of BP to the skin
of Groups 1-3 between the ages of 10
weeks and 55 weeks was associated with
a slight reduction in growth. Weight
gain in Groups 2 and 3, in which BP
treatment was started at 25 and 40 weeks
respectively, was intermediate between
that in Group 1 and that in Group 4.
We do not know whether these differences
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were associate(1 with differences in the
amounts of food consumed. It is con-
cluded that although differences in growth
might have slightly influenced the tumour
crops detected, the effect is unlikely to
have been enouigh to affect our qualitative
conclusions.
Sarcomata
A total of 44 of the .950 mice in the
experiment developed sarcomata arising
in the subcutaneous tissues (I mouse in
Group 1, 3 in Group 2, 10 in Group 3
and 30 in Group 4, between weeks 69
and 121 of age-see Appendix). The
sarcoma incidence rate was found to
depend on age but, given age, not on
the duration of BP treatment (X32 com-
paring age-specific sarcoma incidence rates
in the 4 groups 0.4, indicating no
heterogeneity). This result could be ex-
plained theoretically in one of 2 ways:
either BP has no effect on sarcoma
iincidence at all or BP affects only the
final stage of the carcinogenic process,
while the earlier stages are brought
about by influences other than BP.
From our experimental results alone, it
is not possible to discriminate between
these 2 possibilities as there was no
untreated control group. In previous
skin-painting experiments (e.g. Roe et
al., 1970), female Swiss mice exposed
only to acetone experienced age-specific
incidence rates of the same order as in
the present experiment. It seems likely
therefore that BP has no, or at most a
very small, effect on sarcoma incidence.
As with human sarcomata, the incidence
rate of sarcomata in our experiment
increased less steeply with time than
did the incidence rates of epithelial
tumotirs.
DISCUSSION
We have applied a carcinogen to
the skin of mice up to the extremes of
old age (i.e. 2-3 years) and have observed
that the skin cancer incidence rates
depenid only on duration of carcinogenic
inisuilt and, givein this dturatioin, nlot at
all on the age of the animals when regular
exposure to the insult began (which was
10, 25, 40 or 55 weeks). These results
can be completely explained by the local
multistage model with no intrinsic effect
of age. Although it is possible that an
intrinsic effect of ageing was obscured by
opposing age-related changes in metabolic
activation, deactivation or clearance rates,
hair growth cycles and so on which are
peculiar to our experiment and which
would not necessarily be relevant to
other carcinogens, to other species or to
target tissues other than the skin, there
is no positive reason to suppose that any
such biases have occurred.
Comparison with other experimental findings
A result which apparently contradicts
our findings has been reported by Ebbesen
(1973, 1974), who studied DMBA induced
carcinomata in mouse skin of different
ages transplanted on to syngeneic hosts
of the same age. Although the experi-
mental methods were not reported in
sufficient detail to allow proper evaluation
of the results, it appears that the older
the skin at the time of transplant, the
more susceptible it was to subsequent
tumour induction. Like us, Ebbesen
compared the incidence of skin carcino-
mata in skin aged 1-2 years with the
incidence in skin aged 2-3 years, but
his carcinogenic stimulus was weaker
than ours (2 isolated DMBA applications
resulting in only 10% or so of the animals
developing carcinomata) and it may be
that our stronger stimulus swamped the
spontaneous mutations in the stem cells
of the skin whereas his weaker stimulus
did not. In any case, his results can
be explained naturally under Hypothesis 2
while our results cannot under Hypo-
thesis 1.
However, this explanation raises rather
a delicate point. In our experiment, as
in Ebbesen's experiment, carcinogens are
applied to tissues of different ages to
discover whether, apart from the accu-
mnulation with time of heritable changes
in particular cells, age has any other
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relevance to carcinogensis. If no dif-
ference is observed, as in our experi-
ment, that is evidence that age has no
other relevance and that the spontaneous
rates of each stage were swamped by the
carcinogen induced rates of those stages.
If, however, the older animals are more
vulnerable, as in Ebbesen's experiment,
this can be interpreted as evidence that
the spontaneous accumulation of certain
stages with time is sufficient not to be
swamped by the carcinogen and that
although no other effect of age is relevant,
this accumulation is sufficient to generate
an appreciable difference in vulnerability.
Can the hypothesis of " no other relevance
of age" (Hypothesis 2) ever be contra-
dicted by any conceivable result? It
can, but not by applying carcinogens to
tissues of different ages, as we have done;
our experiment can only contradict Hypo-
thesis 1. A critical experiment for Hypo-
thesis 2 is to apply carcinogens to tissues
of the same age transplanted into hosts
of different ages, but as far as we know
no such experiment has ever been re-
ported.
Another result like Ebbesen's is that
of Berry and Wagner (1975), who have
examined the induction of rat meso-
theliomata by a single intrapleural instil-
lation of asbestos at either 2 or 10 months
of age. If it is assumed that the asbestos
is not eliminated, this constitutes a con-
tinuous carcinogenic stimulus, starting at
the time of the instillation and continuing
until death and it appears, on pre-
liminary inspection of their data, that the
group treated later in life developed
mesotheliomata more rapidly after the
instillation than did the other group.
Again, however, this can be explained
under Hypothesis 2 by assuming that
some ofthe stages occurred spontaneously
to an appreciable extent between months
2 and 10. The experiment of Van
Duuren et al. (1975) on 561 mice may
represent a third such result, but un-
fortunately failure to use life-tables in
describing their findings makes it impos-
sible to discover whether any age-related
differences in tumour inducibility existed.
Finally, Meranze et al. (1969) may have
found one genuine age-related change in
tumour inducibility. 15 mg of intra-
gastric DMBA results in more mammary
tumours in female rats if given at about
6 weeks of age than if given at about 26
weeks of age, even if differences in sub-
sequent duration of exposure are properly
allowed for. This may be due to age-
related hormonal changes which selec-
tively affect mammary tissue, as in adult
human females. However, DMBA in
such enormous doses has many other
systemic effects, particularly on hormonal
status, and it may be these rather than
any more direct carcinogenic effects which
are responsible. Moreover, the dose in
mg per kg body weight was, of course, less
than halfas big in their older animals, and
it is also possible that all Meranze et al.
observed was an age related change in the
effective dose to the target organ.*
Conclusions
Notwithstanding these doubts, our
results certainly show that a power law
increase of incidence with duration of
exposure can arise in the absence of any
intrinsic effects ofage such as, forexample,
decreasing efficiency of immunological
surveillance. (Some independent evi-
dence against the influence, age dependent
or otherwise, of immunological surveil-
lance on cancer incidence already exists,
in that Rygaard and Povlsen (1974) have
shown that mice which were genetically
incapable ofmaking their full complement
of T lymphocytes nevertheless suffered
no appreciable excess of spontaneous
tumours.) By default of other explana-
tions, the increase of those cancer inci-
dence rates which increase approximately
as a power of age appears to occur merely
because as time passes exposure to car-
* The other difficulty that can arise in experiments on the effects of age on the induction of internal
neoplasms, as opposed to skin cancers, is that the greater intercurrent death rates in old animals may
cause more of their internal tumours to be discovered early.
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cinogens and to mistakes in gene replica-
tion during routine mitosis continues,
and heritable changes thus accumulate.
It could still be postulated that the
natural kinetic rate-constants of the
stages strongly affected by our carcinogen
do increase with age, but there seems
no reason to do so. Our results thus
lend some support to the local multistage
hypothesis according to which the kinetic
rate-constants of each stage are (given
which other stages have occurred) largely
independent of age and depend mainly
on the presence and amounts of various
carcinogens and, perhaps, on the rate
of stem cell division in the target tisssue.
Han/an expossure at different ages
Under almost any hypothesis, lifelong
regular exposure of humans to a carcino-
genic insult will be more dangerous the
younger exposure starts. There is, how-
ever, disagreement as to whether brief
exposure is more dangerous for the young
or for the old. Our results suggest that
although the immediate risk to old people
may be greater, the total subsequent
effect of brief exposure to a carcinogenic
insult will eventually be worse in people
exposed when young. (This might not be
true for a brief insult which merely
" promotes " and cannot ' initiate ", but
conversely an insult which merely initiates
and cannot promote would be enormously
more dangerous for people who were
exposed to it when young.)
An utnresolved difficulty
We have shown that the lapse of an
extra year of age before starting treat-
ment (more than one-third of the life
span) does not increase the susceptibility
of mouse skin to benzpyrene carcino-
genesis, nor does it increase the rate of
growth of such tumours once they are
established. Previous work (Lee and
O'Neill, 1971) has shown that in this
system the age specific incidence rate
is proportional to the square of the dose
rate of benzpyrene and it can be shown
that utnder a simple hypothesis such as
that of Armitage and Doll (1961) this
implies that benzpyrene strongly affects
at most two distinct stages. (This con-
clusion is reinforced by unpublished
studies now being analysed by one of us
(PNL) on the pattern of tumour incidence
following discontinuation of benzpyrene
treatment in mice.) Taken together,
these observations suggest either that
there are only 2 stages, in which case it
is very difficult to find models which
lead to a third power law increase with
age, or that, if there are more than
2 stages, benzpyrene acts on the first
stage (and on one later stage) and that
other stages cannot take place until this
first benzpyrene related stage is complete.
Although this sounds rather implausible
(why should certain mutation rates be
increased by benzpyrene while others are
not?), the next paragraph shows that it is
not impossible.
A diploid cell has 2 loci that code
for each enzyme, one on each of a pair
ofhomologous chromosomes. Ifinactiva-
tion of such an enzyme is required during
carcinogenesis, this must occur in 2
stages. In the first stage, the carcinogen
effects a destructive mutation in one of
the loci, converting the cell from AA to
AA (A being inactive). The second
stage might then take place not by a
second destructive mutation but rather
by " mitotic recombination ", a rare error
whereby mitosis results in AA and AA
instead of 2 AA daughters. This provides
a natural mechanism whereby no exo-
genous carcinogen is required to bring
about some of the stages. However,
although such a sequence of events
could explain the third-power dependence
of cancer incidence on duration of ex-
posure observed when benzpyrene is
applied to mouse skin, it is difficult to
see how it alone could lead to the fifth-
and sixth-power dependence on duration
sometimes observed in man, especially
since, in the most extensively studied
human situation (the association between
cigarette smoking and lung cancer), the
cancer incidence rate appears to increase
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only as a single power of dose. The
fact that chronic exposuire to a carcinogen
leads to an incidence rate of cancer which
depends far more strongly on duration of
exposure than oIn dose rate is one of
the most important unexplained features
of the aetiology of cancer in adults.
A possible non-causal link between ageing
and cancer incidence
We have concluded that during normal
life, random heritable changes may occur
by accident in particular stem cells and
that when certain such changes all happen
in a single stem cell the result may
be proliferation into a recognizable cancer.
However, of all the heritable changes that
might occur in a stem cell, the majority
will presumably be irrelevant to carcino-
genesis and so, ignoring lethal changes
which would eliminate a cell line, in old
age several stem cells must have suffered
many non-lethal heritable changes by
the same general mechanisms that are
involved in carcinogenesis. Burnet (1974)
has suggested that this accumulation of
somatic changes is the fundamental pro-
cess of ageing, and that the rate at which
they occur is subject to evolutionary
control (perhaps by inter-species dif-
ferences in the efficiency of the DNA
repair enzymes) and largely determines
the typical lifespan of each species.
These evolved controls on the rates at
which random heritable changes arise
in the stem cells of an organism would
presumably affect not only the timespan
of ageing, but also that of carcinogenesis.
If this is so, then the rate of generation
of somatic mutations determines both the
rate of ageing and the age specific in-
cidence rate of cancer. This postulated
common cause for ageing rates and for
cancer incidence rates might be the
reason why most species suffer some
cancer of old age, whether old age occurs
at 80 weeks or 80 years, even though
ageing itself does not affect oncogenesis.
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APPENDIX
Complete data on the incidence of 10 mm epithelial tumours in the 4 treatment groups,
giving numbers of 10 mm epithelial tumours and of animals charted for each fortnightly
charting at which some 10 mm tumours were found. (The numbers of first sarcomata
are given in brackets at the times when they were first visible, which usually preceded
death by about 5 weeks.)
Group 1 Group 2 Group 3 Group 4
Weeks of (BP from age (BP from age (BP from age (BP from age
benzpyrene 10 weeks) 25 weeks) 40 weeks) 55 weeks)
24 0/135 0/158 0/196 1/369
40 0/130 0/154 1/192 (2a) 1/311 (8b)
42 1/128 1/154 0/190 1/303
44 1/126 0/150 1/187 3/296 (1)
46 2/125 2/149 0/182 2/286 (1)
48 2/123 5/146 1/181 2/275 (2)
50 2/121 0/141 0/176 3/265 (4)
52 6/119 4/141 2/172 1/255
54 2/113 3/137 1/116 6/239 (1)
56 3/111 4/130 4/162 (1) 9/222 (1)
58 10/108 4/126 4/154 (3) 10/203 (4)
60 8/98 9/120 7/149 12/185
62 5/89 7/109 5/137 (1) 14/160 (3)
64 2/82 9/100 (1) 12/129 9/133 (2)
66 10/80 6/88 8/110 (1) 9/110 (3)
68 7/70 10/81 7/97 11/98
70 9/62 17/69 (1) 9/87 (2) 10/77
72 8/52 6/51 (1) 7/74 7/63
74 7/43 8/45 8/65 6/55
76 1/35 7/37 7/51 1/42
78 4/33 6/30 9/42 6/34
80 4/28 (1) 3/23 1/33 7/23
82 3/23 3/20 6/32 1/13
84 4/15 4/16 6/25 0/12
86 4/10 4/12 2/18 0/11
88 1/6 3/8 4/15 2/10*
90 2/5 3/4 0/11
92 0/3 0/1 0/9
94 0/3 0/1 5/9
96 0/3 0/1 2/3
98 0/2 0/1 0/1
100 2/2 0/1 0/1
102 0/0 0/1 O/l
104 0/0 0/it 0/1*
* End of experiment.
t Lived without 10 mm tumour to end of experiment at treatment week 118.
a Weeks 34, 36 of benzpyrene.
b Weeks 14, 14, 18, 22, 36, 36, 38, 38.
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Notes added in proof
(1) At anygiven age, there were no systematic
differences between the four groups in
their death rates from causes other than
10 mm epithelial tumours. (The logrank
chi-square for trend between the four
groups in mortality from such causes was
0.00, showing no trend whatever.) This
suggests that animals only died of treat-
ment via the induction of epithelial
tumours, and supports our belief that
there was no tendency to die of epithelial
tumours before they reached 10 mm.
(One would expect, in an inbred strain,
little heterogeneity in susceptibility to
ageing or to carcinogenesis, and hence no
appreciable within-strain correlation be-
tween these two susceptibilities. This
expectation is also supported by the
above null trend.)
(2) Had a Weibull distribution been fitted to
these data by maximum likelihood, as
suggested by Peto and Lee (1973), the
absolute values ofthe parameters k and w
would have been unduly influenced by the
single tumourless survivor in group 2, and
still more by the early tumour in group 4.
This emphasizes the importance of com-
paring Weibull b-parameters by Cox's
method whenever possible (ibid., p. 468).
(3) It has been suggested that heritable
changes affecting DNA repair enzymes
might accumulate with age, and that when
sufficient such changes have accumulated,
successful cell division is unlikely. This
postulated process (or a modified version
ofit in which the DNA repair enzymes are
so damaged that further damage to the
DNA coding for these enzymes then
occurs rapidly) is referred to as " error
catastrophe ". It has been suggested
that error catastrophe is responsible for
tissue ageing, and that it is responsible
for the increased cancer incidence rates
among old individuals. As we have des-
cribed error catastrophe, changes in one
cell only affect its own descendants and
error catastrophe is merely a particular
example of our " local multistage model "
in which the early stage(s) affect the
repair enzymes. If, implausibly, some
form of change which would affect DNA
repair in all the cells in a tissue similarly
were postulated, then older tissues would
be essentially more vulnerable to carcino-
gens in a manner which has been contra-
dicted by our experiment.
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